Sufeng Zhou
Impact in
-
- Cardiac Fibrosis and Remodeling
-
- Atherosclerosis and Cardiovascular Diseases
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- Cancer therapeutics and mechanisms 5
- Oncology 10
- Metal complexes synthesis and properties 5
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Changzheng Li (13 shared papers)Yun Fu (11 shared papers)Ni Xia (2 shared papers)Xiang Cheng (2 shared papers)Tingting Tang (3 shared papers)Yuhua Liao (2 shared papers)Hong Xiao (2 shared papers)Zhengfeng Zhu (3 shared papers)
- Journals
- Xenobiotica (4 papers)European Journal of Pharmaceutical Sciences (4 papers)Oncology Reports (3 papers)International Journal of Molecular Sciences (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Sufeng Zhou
49 papers receiving 777 citations
Peers
Comparison fields: 5 of 97
- Cardiology and Cardiovascular Medicine 178
- Immunology 129
- Molecular Medicine 30
- Drug Discovery 1
- Biomaterials 77
Countries citing papers authored by Sufeng Zhou
This map shows the geographic impact of Sufeng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sufeng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sufeng Zhou more than expected).
Fields of papers citing papers by Sufeng Zhou
This network shows the impact of papers produced by Sufeng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sufeng Zhou. The network helps show where Sufeng Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Sufeng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 267 | |
| 2 | 2012 | 45 | |
| 3 | 2016 | 41 | |
| 4 | 2013 | 35 | |
| 5 | 2014 | 26 | |
| 6 | 2014 | 26 | |
| 7 | 2014 | 26 | |
| 8 | 2024 | 23 | |
| 9 | 2017 | 20 | |
| 10 | 2014 | 19 | |
| 11 | 2016 | 17 | |
| 12 | 2017 | 16 | |
| 13 | 2016 | 16 | |
| 14 | 2015 | 15 | |
| 15 | 2023 | 14 | |
| 16 | 2021 | 14 | |
| 17 | 2017 | 13 | |
| 18 | 2023 | 13 | |
| 19 | 2016 | 12 | |
| 20 | 2020 | 11 |
About Sufeng Zhou
Sufeng Zhou is a scholar working on Molecular Biology, Oncology, Pharmacology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 50 papers that have together received 784 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Cancer therapeutics and mechanisms (5 papers), Metal complexes synthesis and properties (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Anesthesia and Sedative Agents (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (178 citations), Immunology (129 citations), Molecular Medicine (30 citations), Drug Discovery (1 citation) and Biomaterials (77 citations). Sufeng Zhou has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Changzheng Li, Yun Fu, Ni Xia, Xiang Cheng, Tingting Tang, Yuhua Liao, Hong Xiao, Zhengfeng Zhu, Mengyang Liao and Jing Yuan. Their work appears in journals such as Xenobiotica, European Journal of Pharmaceutical Sciences, Oncology Reports, International Journal of Molecular Sciences and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.